Entia Biosciences, Inc. (ERGO) Investment Research Dashboard
About Entia Biosciences, Inc. (ERGO) stock analysis
Get live ERGO stock price $0.00, comprehensive Entia Biosciences, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time ERGO stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the impr...
Company Information
- CEO
- Timothy A. Timmins
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Employees
- 6
Contact Information
- Website
- https://www.entiabio.com
- Address
- 13565 SW Tualatin-Sherwood Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 27.60)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Entia Biosciences, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Entia Biosciences, Inc.
- ⚠Investors should consider how Entia Biosciences, Inc. fits within their overall portfolio allocation
Market Cap
6.73K
Beta
27.60
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare ERGO with peer companies:
- Price
- $0.00+0.00% (1D)
- Market cap
- 6.89K
- Price
- $0.00+0.00% (1D)
- Market cap
- 5.25K
- Price
- $0.00+0.00% (1D)
- Market cap
- 7.87K
- Price
- $0.00+0.00% (1D)
- Market cap
- 5.45K
- Price
- $0.00+0.00% (1D)
- Market cap
- 12.89K
- Price
- $0.00+0.00% (1D)
- Market cap
- 5.37K
- Price
- $0.00+0.00% (1D)
- Market cap
- 7.00K
- Price
- $0.00+0.00% (1D)
- Market cap
- 67.73K
- Price
- $0.00+0.00% (1D)
- Market cap
- 7.14K
- Price
- $0.00+0.00% (1D)
- Market cap
- 6.76K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
73/100 ⭐⭐⭐⭐⭐
- Overall
- +0.6%
- NYSE
- +0.7%
- NASDAQ
- +0.4%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +1.9% | +2.8% | +4.0% | 19.2 | 98/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.5% | -0.5% | +3.1% | 22.3 | 74/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.6% | +1.2% | +1.5% | 24.0 | 73/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.9% | +1.7% | +0.2% | 25.3 | 66/100⭐⭐⭐⭐ |
| Consumer Defensive | -0.0% | +2.0% | +0.9% | 29.8 | 63/100⭐⭐⭐⭐ |
| Real Estate | +0.4% | +0.9% | -1.6% | 29.5 | 50/100⭐⭐⭐ |
| Energy | -1.7% | -3.3% | -3.7% | 19.2 | 39/100⭐⭐ |
| Utilities | -1.1% | -0.0% | -4.5% | 26.8 | 35/100⭐⭐ |
| Industrials | +0.7% | +0.5% | -9.8% | 30.0 | 21/100⭐ |
| Technology | +0.9% | -1.3% | -6.9% | 40.9 | 18/100⭐ |
| Consumer Cyclical | +0.3% | -1.7% | -6.0% | 42.8 | 14/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.